English | Español

Prostate Cancer Foundation
+ Technology/Innovation
Patient Daily Report | Apr 14, 2023

Research finds promising immunotherapy approach for advanced prostate cancer treatment: 'These findings represent an exciting new opportunity'
+ Community
Carol Ostrow | Dec 2, 2016

Prostate Cancer Foundation partners with VA to increase research

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes